<div id="readability-page-1">Kinsale Capital Group Inc. increased its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 7.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,993 shares of the company's stock after purchasing an additional 1,119 shares during the period. McKesson accounts for approximately 2.3% of Kinsale Capital Group Inc.'s portfolio, making the stock its 14th largest position. Kinsale Capital Group Inc.'s holdings in McKesson were worth $12,355,000 at the end of the most recent quarter.<ul><li>More Than Yield: 5 Stocks Beating the Market and Hiking Dividends</li></ul>Other hedge funds and other institutional investors also recently bought and sold shares of the company. Solstein Capital LLC boosted its holdings in McKesson by 171.4% in the 2nd quarter. Solstein Capital LLC now owns 38 shares of the company's stock valued at $28,000 after purchasing an additional 24 shares in the last quarter. State of Wyoming purchased a new stake in shares of McKesson in the second quarter valued at approximately $29,000. Delos Wealth Advisors LLC acquired a new position in McKesson during the second quarter worth $35,000. Abound Wealth Management raised its position in McKesson by 104.3% in the third quarter. Abound Wealth Management now owns 47 shares of the company's stock worth $37,000 after acquiring an additional 24 shares in the last quarter. Finally, Loomis Sayles &amp; Co. L P acquired a new stake in McKesson in the second quarter valued at $39,000. 85.07% of the stock is currently owned by institutional investors and hedge funds. <h2>McKesson News Roundup</h2>Here are the key news stories impacting McKesson this week:<ul> <li>Positive Sentiment: Q3 results beat consensus: EPS topped estimates and revenue grew ~11.4% year‑over‑year; management raised FY‑2026 adjusted EPS guidance to $38.80–$39.20, underpinning today's rally. McKesson Q3 Earnings Call Highlights</li> <li>Positive Sentiment: Growth drivers called out on the call: oncology, specialty distribution and technology businesses accelerated, which McKesson cites as the basis for the raised profit outlook. MCK Q3 Earnings &amp; Sales Top Estimates, 2026 View Up</li> <li>Positive Sentiment: Strong market reaction: analysts and investors pushed the share price sharply higher on the beat + guidance, citing the bigger‑than‑expected lift to FY26 adjusted EPS. How McKesson Stock Surged 17% In A Day</li> <li>Neutral Sentiment: Analyst target changes mixed: some firms raised price targets (e.g., Wells Fargo, Mizuho) but ratings stayed neutral/equal‑weight, leaving upside expectations varied among brokers. Price Target Raised to $925.00 at Wells Fargo &amp; Company</li> <li>Neutral Sentiment: Company materials and transcripts are available for detailed review (presentation and full earnings call transcript) — useful for checking segment KPIs, margin drivers and guidance assumptions. Q3 2026 earnings call transcript</li> <li>Negative Sentiment: Operational cash flow weakness flagged: some reports note weaker operating cash flow despite profit growth, and balance‑sheet metrics (higher liabilities) warrant watching for sustainability of buybacks/dividends. EPS Beats, Profit Growth but Weak Operating Cash Flow</li> <li>Negative Sentiment: Insider selling is noted in recent filings; combined with high share price momentum, this can contribute to near‑term volatility or profit‑taking. Insider Trading and Hedge Fund Activity</li> </ul><h2>McKesson Trading Down 1.0%</h2><ul><li>3 Safe Dividend Stocks as Investors Seek to Reset Diversification</li></ul>NYSE:MCK opened at $947.96 on Friday. The firm has a market cap of $116.12 billion, a price-to-earnings ratio of 27.26, a price-to-earnings-growth ratio of 1.55 and a beta of 0.40. The company's 50-day moving average is $828.41 and its two-hundred day moving average is $780.06. McKesson Corporation has a 12-month low of $583.55 and a 12-month high of $971.93. McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts' consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company's quarterly revenue was up 11.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities research analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year. <h2>McKesson Dividend Announcement</h2><ul><li> 3 Stocks to Consider With a Possible Recession on the Table</li></ul>The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. McKesson's dividend payout ratio is currently 9.43%. <h2>Wall Street Analyst Weigh In</h2>Several brokerages recently commented on MCK. Mizuho raised their price objective on shares of McKesson from $880.00 to $885.00 and gave the company a &#34;neutral&#34; rating in a research note on Thursday. Zacks Research downgraded shares of McKesson from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, November 25th. Robert W. Baird set a $968.00 price target on McKesson in a research note on Wednesday, January 14th. Barclays assumed coverage on McKesson in a report on Monday, December 8th. They issued an &#34;overweight&#34; rating and a $960.00 price target on the stock. Finally, TD Cowen lifted their price objective on McKesson from $1,000.00 to $1,012.00 and gave the stock a &#34;buy&#34; rating in a report on Thursday. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $918.93.Get Our Latest Report on McKesson<h2>Insider Buying and Selling at McKesson</h2>In related news, EVP Thomas L. Rodgers sold 276 shares of the business's stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the sale, the executive vice president directly owned 2,268 shares in the company, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. 0.08% of the stock is currently owned by insiders. <h2>McKesson Profile</h2> (Free Report)McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies. The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.<h2>Read More</h2><ul><li>Five stocks we like better than McKesson</li><li>The buying spree that no one is talking about</li><li>Virtually Limitless Energy</li><li>The $650 Million Bet on AI's Future</li><li>The gold chart Wall Street is terrified of…</li><li>NEW LAW: Congress Approves Setup For Digital Dollar?</li></ul>Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).<img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1DSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1DSw"/>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.<h2>Should You Invest $1,000 in McKesson Right Now?</h2>Before you consider McKesson, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here </div>

KNSL

Kinsale Capital Group Inc. increased its stake in McKesson Corporation (NYSE:MCK) by 7.5% in Q3, owning 15,993 shares valued at $12.36 million. Other institutional investors also boosted their holdings. McKesson's Q3 results exceeded expectations, with a revenue growth of 11.4% year-over-year and raised FY-2026 EPS guidance. However, concerns about operational cash flow and insider selling may lead to volatility. McKesson's stock opened at $947.96, with a market cap of $116.12 billion and a P/E ratio of 27.26.

McKesson Corporation $MCK Shares Acquired by Kinsale Capital Group Inc.